Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2513-2520

  Petersen, Cordula ^a   Petersen, Sven ^a   Milas, Luka ^a   Lang, Frederick F ^a   Tofilon, Philip J ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL SURVIVAL; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; TUMOR GROWTH;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL CYCLE; CELL SURVIVAL; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FLOW CYTOMETRY; GLIOMA; HUMANS; IN SITU NICK-END LABELING; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; RNA, MESSENGER; SULFONAMIDES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034124894     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bates, E. J. Eicosanoids, fatty acids, and neutrophils: their relevance to the pathobiology of disease. Prostaglandins Leukot. Essent. Fatty Acids, 53: 75-86, 1995.
2. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J. Natl. Cancer Inst., 90: 1609-1620, 1998.
3. Lupulescu, A. Prostaglandins, their inhibitors and cancer. Prostaglandins Leukot. Essent. Fatty Acids, 54: 83-94, 1996.
4. Honn, K. V., Bockman, R. S., and Marnett, L. J. Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins, 21: 833-864, 1981.
5. Paoletti, P., Chiabrando, C., Gaetani, P., Castelli, M. G., Butti, G., Martelli, L., and Rolli, M. Prostaglandins in human brain tumors. J. Neurosurg., 33: 65-69, 1989.
6. Pairet, M., and Engelhardt, G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam. Clin. Pharmacol., 10: 1-17, 1996.
7. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
8. Tucker, O. N., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., and Fahey, T. J., III. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59: 987-990, 1999.
9. Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D. G., and Mukhtar, H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate, 42: 73-78, 2000.
10. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
11. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59: 991-994, 1999.
12. Dannenberg, A. J., and Zakim, D. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin. Oncol., 26: 499-504, 1999.
13. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
14. Harris, R. E., Namboodiri, K. K., and Farrar, W. B. Nonsteroidal anti-inflammatory drugs and breast cancer. Epidemiology, 7: 203-205, 1996.
15. Reddy, B. S., Maruyama, H., and Kelloff, G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res., 47: 5340-5346, 1987.
16. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 5: 1464-1472, 1995.
17. Palayoor, S. T., Bump, E. A., Calderwood, S. K., Bartol, S., and Coleman, C. N. Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin. Cancer Res., 4: 763-771, 1998.
18. Piazza, G. A., Rahm, A. K., Finn, T. S., Fryer, B. H., Li, H., Stoumen, A. L., Pamukcu, R., and Ahnen, D. J. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer Res., 57: 2452-2459, 1997.
19. Shiff, S. J., Koutsos, M. I., Qiao, L., and Rigas, B. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res., 222: 179-188, 1996.
20. Milas, L., Furuta, Y., Hunter, N., Nishiguchi, I., and Runkel, S. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Res., 50: 4473-4477, 1990.
21. Furuta, Y., Hunter, N., Barkley, T., Jr., Hall, E., and Milas, L. Increase in radioresponse of murine tumors by treatment with indomethacin. Cancer Res., 48: 3008-3013, 1988.
22. Teicher, B., Bump, E. A., Palayoor, S. T., Northey, D., and Coleman, C. N. Signal transduction inhibitors as modifiers of radiation therapy in human prostate carcinoma xenografts. Radiat. Oncol. Invest., 4: 221-230, 1996.
23. Taketo, M. M. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J. Natl. Cancer Inst., 90: 1529-1536, 1998.
24. DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., Van De Putte, L. B., and Lipsky, P. E. Cyclooxygenase in biology and disease. FASEB J., 12: 1063-1073, 1998.
25. Milas, L., Kishi, K., Hunter, N., Mason, K., Masferrer, J. L., and Tofilon, P. J. Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme. J. Natl. Cancer Inst., 91: 1501-1504, 1999.
26. Kishi, K., Petersen, S., Petersen, C., Hunter, N., Masferrer, J. L., Tofilon, P. J., and Milas, L. Preferential enhancement of tumor radioresponse by a COX-2 inhibitor. Cancer Res., 60: 1326-1331, 2000.
27. Hanson, W. R. Eicosanoid-induced radioprotection and chemoprotection of normal tissue during cancer treatment. In: J. E. Harris, D. P. Braun, and K. M. Anderson (eds.), Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy, pp. 171-186. Boca Raton, FL: CRC Press, 1994.
28. Shrieve, D. C., Alexander, E., III, Black, P. M., Wen, P. Y., Fine, H. A., Kooy, H. M., and Loeffler, J. S. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J. Neurosurg., 90: 72-77, 1999.
29. Kaufmann, W. E., Andreasson, K. I., Isakson, P. C., and Worley, P. F. Cyclooxygenases and the central nervous system. Prostaglandins. 54: 601-624, 1997.
30. Fertil, B., and Malaise, E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Biol., 7: 621-629, 1981.
31. O'Brien, M. C., Healy, S. F., Jr., Raney, S. R., Hurst, J. M., Avner, B., Hanly, A., Mies, C., Freeman, J. W., Snow, C., Koester, S. K., and Bolton, W. E. Discrimination of late apoptotic/necrotic cells (type III) by flow cytometry in solid tumors. Cytometry, 28: 81-89, 1997.
32. Gonczyca, W., Bruno, S., Darzynkiewicz, R. J., Gong, J., and Darzynkiewicz, Z. DNA strand breaks occurring in apoptosis: their early detection by deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int. J. Oncol., 1: 639-648, 1992.
33. Battu, S., Chable-Rabinovitch, H., Rigaud, M., and Beneytout, J. L. Cyclooxygenase-2 expression in human adenocarcinoma cell line HT29 cl.19A. Anticancer Res., 18: 2397-2403, 1998.
34. Elder, D. J., Halton, D. E., Hague, A., and Paraskeva, C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin. Cancer Res., 3: 1679-1683, 1997.
35. Otto, J. C., DeWitt, D. L., and Smith, W. L. N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268: 18234-18242, 1993.
36. Yamamoto, T., and Sakashita, Y. COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA. Neuroreport, 9: 3869-3873, 1998.
37. Nogawa, S., Zhang, R. Ross, M. E., and Iadecola, C. Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci., 17: 2746-2755, 1997.
38. Kinouchi, H., Huang, H., Arai, S., Mizoi, K., and Yoshimoto, T. Induction of cyclooxygenase-2 messenger RNA after transient and permanent middle cerebral artery occlusion in rats: comparison with c-fos messenger RNA by using in situ hybridization. J. Neurosurg., 91: 1005-1012, 1999.
39. Nakayama, M., Uchimura, K., Zhu, R. L., Nagayama, T., Rose, M. E., Stetler, R. A., Isakson, P. C., Chen, J., and Graham, S. H. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Pharmacology, 95: 10954-10959, 1998.
40. Kelley, K. A., Ho, L., Winger, D., Freire-Moar, J., Borelli, C. B., Aisen, P. S., and Pasinetti, G. M. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol., 155: 995-1004, 1999.
41. Ho, L., Pieroni, C., Winger, D., Purohit, D. P., Aisen, P. S., and Pasinetti, G. M. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J. Neurosci. Res., 57: 295-303, 1999.
42. Yasojima, K., Schwab, C., McGeer, E. G., and McGeer, P. L. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res., 830: 226-236, 1999.
43. McGeer, P. L., Schulzer, M., and McGeer, E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology, 47: 425-432, 1996.
44. Kakeji, Y., and Teicher, B. A. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents. Investig. New Drugs, 15: 39-48, 1997.
45. Gorski, D. H., Mauceri, H. J., Salloum, R. M., Gately, S., Hellman, S., Beckett, M. A., Sukhatme, V. P., Soff, G. A., Kufe, D. W., and Weichselbaum, R. R. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res., 58: 5686-5689, 1998.
46. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.